DENTAL RESIN MODIFIED GLASS-IONOMER COMPOSITION AND KIT COMPRISING SAID COMPOSITION

Abstract

The present invention is related to a dental resin modified glass-ionomer composition comprising (a) water; (b) at least one polycarboxylic acid; (c) at least one compound having at least one phosphorous atom; and (d) at least one bisacrylamide having formula (I). The present invention is further related to a kit comprising such a dental resin modified glass-ionomer composition.

##STR00001##

Claims

1. Dental resin modified glass-ionomer composition comprising: (a) water; (b) at least one polycarboxylic acid; (c) at least one compound having at least one phosphorous atom selected from the group consisting of a (meth)acrylate having at least one phosphate group, a (meth)acrylate having at least one phosphonate group, a (meth)acrylamide having at least one phosphate group, a (meth)acrylamide having at least one phosphonate group, an acrylic ether having at least one phosphate group, and an acrylic ether having at least one phosphonate group; and (d) at least one bisacrylamide having a following formula (I): ##STR00010## wherein R.sub.1=hydrogen, a C.sub.1 to C.sub.18 alkyl group, a C.sub.3 to C.sub.18 alkylene group comprising at least one carbon-carbon double bond, a C.sub.3 to C.sub.18 cycloalkyl group, or a C.sub.4 to C.sub.18 aryl group; R.sub.2=a difunctional C.sub.1 to C.sub.18 alkyl group, a difunctional C.sub.4 to C.sub.18 alkylene group comprising at least one carbon-carbon double bond, a difunctional C.sub.3 to C.sub.18 cycloalkyl group, a difunctional C.sub.5 to C.sub.18 aryl group, or a difunctional C.sub.1 to C.sub.18 hydrocarbon moiety being substituted with at least one acrylamide or acrylate group(s); and R.sub.3=hydrogen, a C.sub.1 to C.sub.18 alkyl group, a C.sub.3 to C.sub.18 alkylene group comprising at least one carbon-carbon double bond, a C.sub.3 to C.sub.18 cycloalkyl group, or a C.sub.5 to C.sub.18 aryl group.

2. Dental resin modified glass-ionomer composition according to claim 1 wherein the at least one compound having at least one phosphorous atom is selected from the group consisting of 2-(meth)acryloyloxyethyldihydrogen phosphate, bis[2-(meth)acryloyloxyethyl]hydrogen phosphate, 2-(meth)acryloyloxyethylphenylhydrogen phosphate, 6-(meth)acryloyloxyhexyldihydrogen phosphate, 6-(meth)acryloyloxyhexylphenylhydrogen phosphate, 10-(meth)acryloyloxydecyldihydrogen phosphate, 1,3-di(meth)acryloylpropane-2-dihydrogen phosphate, 1,3-di(meth) acryloylpropane-2-phenylhydrogen phosphate, dipentaerythrolpentaacryloyl dihydrogen phosphate, ethyl 2-[5-dihydrogen phosphoryl-5.2-dioxa pentyl]acrylate, and bis[5-{2-(meth)acryloyloxyethoxycarbonyl}heptyl]hydrogen phosphate.

3. Dental resin modified glass-ionomer composition according to claim 2 wherein the at least one compound having at least one phosphorous atom is selected from the group consisting of 10-methacryloyloxydecyldihydrogen phosphate, dipentaerythrolpentaacryloyl dihydrogen phosphate, and ethyl 2-[5-dihydrogen phosphoryl-5.2-dioxa pentyl]acrylate.

4. Dental resin modified glass-ionomer composition according to claim 1 wherein the dental resin modified glass-ionomer composition is substantially free of ascorbic acid and a salt thereof; wherein “substantially free” means a concentration of less than 5 weight percent based on a total weight of the dental resin modified glass-ionomer composition.

5. Dental resin modified glass-ionomer composition according to claim 1 wherein the dental resin modified glass-ionomer composition is substantially free of a (meth)acrylate not having at least one phosphorous atom; wherein “substantially free” means in a concentration of less than 5 weight percent based on a total weight of the dental resin modified glass-ionomer composition.

6. Dental resin modified glass-ionomer composition according claim 1 further comprising (e) at least one acrylamide having a following formula (11): ##STR00011## wherein R.sub.4=hydrogen, a C.sub.1 to C.sub.18 alkyl group, a C.sub.3 to C.sub.18 alkylene group comprising at least one carbon-carbon double bond, a C.sub.3 to C.sub.18 cycloalkyl group, or a C.sub.5 to C.sub.18 aryl group; R.sub.5=hydrogen, a C.sub.1 to C.sub.18 alkyl group, a C.sub.3 to C.sub.18 alkylene group comprising at least one carbon-carbon double bond, a C.sub.3 to C.sub.18 cycloalkyl group, or a C.sub.5 to C.sub.18 aryl group; and wherein the term “alkyl group” for R.sub.4 and R.sub.5 refers to a linear or branched saturated hydrocarbon chain of the respective length, which may be substituted further with one or more substituents such as alkylene, alkoxy, nitrile, aryl, cycloalkyl, and hydroxyl.

7. Dental resin modified glass-ionomer composition according to claim 6 wherein the at least one acrylamide is selected from the group consisting of N-methylolacrylamide, N-methylolmethacrylamide, N-(2-hydroxyethyl)-methacrylamide, N-methyl-N-(2-hydroxyethyl)-acrylamide, N-methacryloyl-1-aminosalicylic acid, N-acryloyl aspartic acid, and N-methacryloyl glycine.

8. Dental resin modified glass-ionomer composition according to claim 1 wherein the at least one bisacrylamide is selected from the group consisting of N,N′-dimethyl-1,3-bis(acrylamido)-propane, N,N′-dimethyl-1,3-bis(acrylamido)-hexane, N,N′-diethyl-1,3-bis(acrylamido)-propane, and N,N′-bisacryloyl-N,N′-bisallyl-1,4-but-2-en-diamine.

9. Dental resin modified glass-ionomer composition according to claim 1 further comprising (f) at least one reactive filler.

10. Dental resin modified glass-ionomer composition according to claim 1 wherein the at least one polycarboxylic acid is a copolymer or homopolymer of at least one of the monomers acrylic acid, methacrylic acid, 2-chloroacrylic acid, 3-chloroacrylic acid, aconitic acid, mesaconic acid, maleic acid, itaconic acid, fumaric acid, glutaconic acid, or citraconic acid.

11. Dental resin modified glass-ionomer composition according to claim 1 further comprising (g) at least one non-reactive filler.

12. Dental resin modified glass-ionomer composition according to claim 1 further comprising (h) at least one polymerization initiator system selected from the group consisting of a photoinitiator system, a redox initiator system, and a combination thereof.

13. Kit comprising a dental resin modified glass-ionomer composition comprising at least a first part and at least a second part; wherein the first part comprises at least one compound having at least one phosphorous atom selected from the group consisting of a (meth)acrylate having at least one phosphate group, a (meth)acrylate having at least one phosphonic acid group, and an acrylic ether having at least one phosphonic acid group; and at least one bisacrylamide having a formula (I): ##STR00012## wherein R.sub.1=hydrogen, a C.sub.1 to C.sub.18 alkyl group, a C.sub.3 to C.sub.18 alkylene group comprising at least one carbon-carbon double bond, a C.sub.3 to C.sub.18 cycloalkyl group, or a C.sub.5 to C.sub.18 aryl group; R.sub.2=a difunctional C.sub.1 to C.sub.18 alkyl group, a difunctional C.sub.4 to C.sub.18 alkylene group comprising at least one carbon-carbon double bond, a difunctional C.sub.3 to C.sub.18 cycloalkyl group, a difunctional C.sub.5 to C.sub.18 aryl group, or a difunctional C.sub.1 to C.sub.18 hydrocarbon moiety being substituted with at least one acrylamide or acrylate group(s); and R.sub.3=hydrogen, a C.sub.1 to C.sub.18 alkyl group, a C.sub.3 to C.sub.18 alkylene group comprising at least one carbon-carbon double bond, a C.sub.3 to C.sub.18 cycloalkyl group, or a C.sub.5 to C.sub.18 aryl group. and wherein the second part comprises at least water; at least one polycarboxylic acid; and at least one bisacrylamide having the formula (I).

14. Kit according to claim 13 wherein the first part further comprises at least one reactive filler, preferably a fluoroaluminosilicate filler; and the second part further comprises at least one acrylamide having a formula (II): ##STR00013## wherein R.sub.4=hydrogen, a C.sub.1 to C.sub.18 alkyl group, a C.sub.3 to C.sub.18 alkylene group comprising at least one carbon-carbon double bond, a C.sub.3 to C.sub.18 cycloalkyl group, or a C.sub.5 to C.sub.18 aryl group; R.sub.5=hydrogen, a C.sub.1 to C.sub.18 alkyl group, a C.sub.3 to C.sub.18 alkylene group comprising at least one carbon-carbon double bond, a C.sub.3 to C.sub.18 cycloalkyl group, or a C.sub.5 to C.sub.18 aryl group; and wherein the term “alkyl group” for R.sub.4 and R.sub.5 refers to a linear or branched saturated hydrocarbon chain of the respective length, which may be substituted further with one or more substituents such as alkylene, alkoxy, nitrile, aryl, cycloalkyl, and hydroxyl; and at least one non-reactive filler.

15. Kit according to claim 13 wherein the first part and the second part are a paste, respectively; or wherein the first part is a powder and the second part is a liquid.

Description

DETAILED DESCRIPTION OF THE INVENTION

[0030] The expression “substantially free” means in the context of the present invention a concentration of less than 5 weight percent, preferably less than 2.5 weight percent, and more preferably less than 1 weight percent based on the total weight of the dental (RMGI) composition.

[0031] As used herein, the term “resin modified glass-ionomer (RMGI)” and the alternative term “resin modified glass-ionomer (RMGI) cement” are exchangeable in the context of the present invention.

[0032] The term “(meth)acrylate” in the context of the present disclosure is meant to refer to the acrylate as well as to the corresponding methacrylate.

[0033] The term “hydrocarbon moiety” refers to a linear or branched saturated or unsaturated hydrocarbon chain of the respective length. Such a hydrocarbon moiety may be substituted further with one or more substituents such as alkylene, alkoxy, acrylamide, acrylate, nitrile, aryl, cycloalkyl, and hydroxyl.

[0034] The term “alkyl group” refers to a linear or branched saturated hydrocarbon chain of the respective length. This term can be exemplified by groups such as methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, t-butyl, n-pentyl, isopentyl, neopentyl, n-hexyl, n-decyl, dodecyl, tetradecyl, and the like. Such alkyl groups may be substituted further with one or more substituents such as alkylene, alkoxy, nitrile, aryl, cycloalkyl, and hydroxyl.

[0035] The term “alkylene group” refers to a linear or branched hydrocarbon chain of the respective length, which comprises at least one carbon-carbon double bond. Such alkylene groups may be substituted further with one or more substituents such as alkyl, alkoxy, nitrile, aryl, cycloalkyl, and hydroxyl.

[0036] The term “aryl group” refers to an aromatic, heterocyclic, fused aromatic, fused heterocyclic, biaromatic, or bihetereocyclic ring systems having the given specific number of carbon atoms. Broadly defined, “aryl”, as used herein, includes 5 to 18-membered single-ring aromatic groups that may include from zero to four heteroatoms, for example, benzene, pyrrole, furan, thiophene, imidazole, oxazole, thiazole, triazole, pyrazole, pyridine, pyrazine, pyridazine, pyrimidine, and the like. Those “aryl” groups having heteroatoms in the ring structure may also be referred to as “heteroaryl” or “heterocycles” or “heteroaromatics”. The aromatic ring can be substituted at one or more ring positions with one or more substituents such as halogen, alkyl, alkylene, cycloalkyl, hydroxyl, and alkoxy.

[0037] The term “cycloalkyl group” refers to monocyclic or polycyclic cycloalkyl group. Examples include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl. Examples of polycyclic cycloalkyl groups include, for example admantyl, norbornyl, decalinyl, 7,7-dimethyl-bicyclo[2.2.1]heptanyl, tricyclo[5.2.1.02,6]decyl and the like. Such a cycloalkyl group may be substituted further with one or more substituents such as alkyl, alkoxy, nitrile, aryl, cycloalkyl, and hydroxyl.

[0038] For component (a), water provides a medium needed for the ionic acid-base reaction to take place between the polycarboxylic acid (b) and the fluoro-alum inosilicate filler (f). According to embodiments of the present invention, water (a) may be present in an amount from 0.5 to 40 weight percent, preferably from 1.0 to 30 weight percent, and more preferably from 2.0 to 25 weight percent based on the total weight of the dental RMGI composition.

[0039] For component (c), at least one compound having at least one phosphorous atom, which is selected from the group consisting of a (meth)acrylate having at least one phosphate group, a (meth)acrylate having at least one phosphonate group, a (meth)acrylamide having at least one phosphate group, a (meth)acrylamide having at least one phosphonate group, an acrylic ether having at least one phosphate group, and an acrylic ether having at least one phosphonate group; is comprised by the inventive dental RMGI composition.

[0040] Such a phosphorous containing polymerizable monomer is commonly only comprised in water-free self-adhesive resin cements (also called SARC's). These SARC's provide good aesthetics, good (in comparison to a RMGI composition superior) adhesive abilities to dentin but suffers from bad applicability for the customer.

[0041] Such a phosphorous containing polymerizable monomer is up to now never comprised in water containing RMGI compositions, which provide bad aesthetics, bad (in comparison to a resin cement inferior) adhesive abilities to dentin, but good applicability for the customer.

[0042] Such a compound having at least one phosphorous atom can be a (meth)acrylate having at least one phosphate group. The term “phosphate group” includes in the present invention also the possibility of having a phosphoric acid group, wherein each R residue of each oxygen atom of the phosphate group is hydrogen, such as shown below by MEP, GDMP, MDP, or PENTA-P.

[0043] Certain specific examples are given herewith in the following:

##STR00003##

[0044] Such a compound having at least one phosphorous atom can be also a (meth)acrylamide having at least one phosphate group, wherein (compared to the (meth)acrylate) the oxygen atom of each (meth)acrylic ester group is substituted by a nitrogen atom forming thereby an (meth)acrylamide instead of an (meth)acrylate.

[0045] Such a compound having at least one phosphorous atom can be also a (meth)acrylate having at least one phosphonate group. The term “phosphonate group” includes in the present invention also the possibility of having a phosphonic acid group, wherein each R residue of each oxygen atom of the phosphonate group is hydrogen, such as shown below by MAPA-1 or MAPA-2.

##STR00004##

[0046] Such a compound having at least one phosphorous atom can be also a (meth)acrylamide having at least one phosphonate group, wherein (compared to the (meth)acrylate) the oxygen atom of each (meth)acrylic ester group is substituted by a nitrogen atom forming thereby an (meth)acrylamide instead of an (meth)acrylate.

[0047] Such a compound having at least one phosphorous atom can be also an acrylic ether having at least one phosphonate group. Some examples are given below:

##STR00005##

[0048] Such a compound having at least one phosphorous atom can be also an acrylic ether having at least one phosphate group.

[0049] All compounds having at least one phosphorous atom of component (c) being comprised in the dental RMGI composition (or in all parts of a kit, if a kit is present) are provided in an amount of 2 to 30 weight percent, preferably 3 to 20 weight percent, and more preferably 4 to 10 weight percent based on the total weight of the dental RMGI composition.

[0050] In one embodiment, the at least one compound having at least one phosphorous atom is selected from the group consisting of 2-(meth)acryloyloxyethyldihydrogen phosphate, bis[2-(meth)acryloyloxyethyl]hydrogen phosphate, 2-(meth)acryloyloxyethylphenylhydrogen phosphate, 6-(meth)acryloyloxyhexyldihydrogen phosphate, 6-(meth)acryloyloxyhexylphenylhydrogen phosphate, 10-(meth)acryloyloxydecyldihydrogen phosphate, 1,3-di(meth)acryloylpropane-2-dihydrogen phosphate, 1,3-di(meth) acryloylpropane-2-phenylhydrogen phosphate, dipentaerythrolpentaacryloyl dihydrogen phosphate, ethyl 2-[5-dihydrogen phosphoryl-5.2-dioxa pentyl]acrylate, and bis[5-{2-(meth)acryloyloxyethoxycarbonyl} heptyl]hydrogen phosphate.

[0051] In a preferred embodiment thereof, the at least one compound having at least one phosphorous atom is selected from the group consisting of 10-methacryloyloxydecyldihydrogen phosphate (MDP), dipentaerythrolpentaacryloyl dihydrogen phosphate (PENTA-P), and ethyl 2-[5-dihydrogen phosphoryl-5.2-dioxa pentyl]acrylate (DHPOBA).

[0052] Particularly, these three individual compounds are preferred because of having excellent adhesive property and self-stability of an acrylate compound.

[0053] For component (d), at least one bisacrylamide having formula (I) as cited above is comprised.

[0054] Such a bisacrylamide provides a superior stability versus hydrolysis (less than 20% will be normally hydrolyzed, such as in the presence of water and an acid, such as methyl sulfonic acid (MSA) at 50° C. in a given period of time) in comparison to the commonly used (meth)acrylates not having at least one phosphorous atom (up to 80% will be normally hydrolyzed, such as in the presence of water and an acid, such as methyl sulfonic acid (MSA) at 50° C. in a given period of time). These commonly used esters of acrylic or methacrylic acid are known in the prior art to be sensible to such environmental conditions for hydrolysis (presence of water and acid). However, hydrolysis stability of (meth)acrylates is problematic in view of the acidity of many dental compositions which severely limits the storage stability of the dental composition. Moreover, hydrolysis taking place under biological conditions in the mouth of the patient is a further concern regarding (meth)acrylates.

[0055] Such a bisacrylamide can be exemplarily:

##STR00006##

[0056] All bisacrylamides according to formula (I) being comprised in the dental RMGI composition (or in all parts of a kit, if a kit is present) are provided in an amount of 10 to 60 weight percent, preferably 15 to 50 weight percent, and more preferably 20 to 40 weight percent based on the total weight of the dental RMGI composition.

[0057] In an embodiment, wherein R.sub.2 is a difunctional C.sub.1 to C.sub.18 hydrocarbon moiety being substituted with at least one, preferably one or two, acrylamide or acrylate group(s), it is still referred to as “bisacrylamide” in the context of the present invention, even when in case of comprising one or two further acrylamide group(s), it will represent a trisacrylamide or a tetra-acrylamide. In case of comprising at least one acrylate group a “mixed structure” comprising at least two acrylamide groups and at least one ester group is generated.

[0058] In one embodiment, the at least one bisacrylamide is selected from the group consisting of N,N″-dimethyl-1,3-bis(acrylamido)-propane, N,N″-dimethyl-1,3-bis(acrylamido)-hexane, N,N″-diethyl-1,3-bis(acrylamido)-propane (BADEP), and N,N″-bisacryloyl-N,N″-bisallyl-1,4-but-2-en-diamine (BAABE).

[0059] In one embodiment, the dental resin modified glass-ionomer composition is substantially free, preferably completely free, of ascorbic acid and a salt thereof; wherein the expression “substantially free” means in the context of the present invention a concentration of less than 5 weight percent, preferably less than 2.5 weight percent, and more preferably less than 1 weight percent based on the total weight of the dental (RMGI) composition.

[0060] The dental resin modified glass-ionomer composition of the present invention is especially substantially free, preferably completely free, of L(+)ascorbic acid, L(+)-calcium ascorbate, L(+)-sodium ascorbate, dehydroascorbic acid, isoascorbic acid, sodium isoascorbate, (+)-5,6-0-isopropylidene-L-ascorbic acid, 2,6-di-0-palmitoyl-L-ascorbic acid, 6-0-palmitoyl-L-ascorbic acid, D-araboascorbic acid, or the like.

[0061] In one embodiment, the dental resin modified glass-ionomer composition further comprises

[0062] (e) at least one acrylamide having the following formula (II):

##STR00007##

[0063] wherein [0064] R.sub.4=hydrogen, a C.sub.1 to C.sub.18 alkyl group, a C.sub.3 to C.sub.18 alkylene group comprising at least one carbon-carbon double bond, a C.sub.3 to C.sub.18 cycloalkyl group, or a C.sub.5 to C.sub.18 aryl group; and [0065] R.sub.5=hydrogen, a C.sub.1 to C.sub.18 alkyl group, a C.sub.3 to C.sub.18 alkylene group comprising at least one carbon-carbon double bond, a C.sub.3 to C.sub.18 cycloalkyl group, or a C.sub.5 to C.sub.18 aryl group; and wherein [0066] the term “alkyl group” for R.sub.4 and R.sub.5 refers herein to a linear or branched saturated hydrocarbon chain of the respective length, which may be substituted further with one or more substituents such as alkylene, alkoxy, nitrite, aryl, cycloalkyl, and hydroxyl.

[0067] For component (e), at least one acrylamide having formula (II) as cited above is comprised.

[0068] All acrylamides having formula (II) being comprised in the dental RMGI composition (or in all parts of a kit, if a kit is present) are provided in an amount of 2 to 15 weight percent, preferably 2 to 9 weight percent, and more preferably 3 to 5 weight percent based on the total weight of the dental RMGI composition.

[0069] A possible example is:

##STR00008##

[0070] In a preferred embodiment thereof, the at least one acrylamide is selected from the group consisting of N-methylolacrylamide, N-methylolmethacrylamide, N-(2-hydroxyethyl)-methacrylamide, N-methyl-N-(2-hydroxyethyl)-acrylamide, N-methacryloyl-1-aminosalicylic acid, N-acryloyl aspartic acid, and N-methacryloyl glycine.

[0071] In one embodiment, the dental resin modified glass-ionomer composition is substantially free, preferably completely free, of a (meth)acrylate not having at least one phosphorous atom; wherein the expression “substantially free” means in the context of the present invention a concentration of less than 5 weight percent, preferably less than 2.5 weight percent, and more preferably less than 1 weight percent based on the total weight of the dental (RMGI) composition.

[0072] Such a (meth)acrylate not having at least one phosphorous atom can be exemplarily one of the following known esters:

##STR00009##

[0073] In one embodiment, the dental resin modified glass-ionomer composition further comprises

[0074] (f) at least one reactive filler, preferably a fluoroaluminosilicate filler.

[0075] Fluoroaluminosilicate fillers are ionically reactive towards acids, such as the polycarboxylic acid (b). As used herein, “ionically reactive” means when the finely divided fluoroaluminosilicate filler (f) and the polycarboxylic acid (b) are mixed together in the presence of water (a), either viscosity increase or hardening of the mixed composition can be observed. According to embodiments of the present invention, the fluoroaluminosilicate filler is a finely divided filler with mean particle size in the range of about 0.02 microns to about 20 microns. The mean particle size of the finely divided fluoroaluminosilicate filler can be measured by a conventional particle size measurement instrument that employs laser light scattering methodology. In one embodiment, the mean particle size of the finely divided fluoroaluminosilicate filler is in the range from about 0.10 microns to about 10 microns. According to one aspect, the finely divided fluoroaluminosilicate filler can further contain calcium, strontium, barium, a rare earth metal, zirconium, zinc, and combinations thereof. Exemplary rare earth metals include, but are not limited to, ytterbium, yttrium, or combinations thereof. In one embodiment, the surface of the fluoroaluminosilicate filler is treated or coated with a coupling agent to enhance the interfacial bonding between the filler and resin matrix and improve mechanical properties. In one embodiment, the coupling agent is a silane compound having at least one polymerizable group selected from the group consisting of an acrylate, a methacrylate, an acrylamido, a methacrylamido, and a vinyl group. Useful examples of coupling agents include, but are not limited to, y-methacryloyloxypropyl trimethoxysilane (MPTMS), γ-methacryloyloxypropyl triethoxysilane, γ-methacryloyloxypropyl methyldimethoxysilane, vinyltrimethoxysilane, and vinyltriethoxysilane. Another useful example of a coupling agent is a compound that has an acid functional group and a polymerizable group selected from the group consisting of an acrylate, a methacrylate, an acrylamido, a methacrylamido, and a vinyl group. Useful examples include, but are not limited to, acrylic acid, methacrylic acid, and maleic acid.

[0076] All fluoroaluminosilicate fillers of component (f) being comprised in the dental RMGI composition (or in all parts of a kit, if a kit is present) are provided in an amount of 10 to 55 weight percent, preferably 15 to 40 weight percent, and more preferably 25 to 35 weight percent based on the total weight of the dental RMGI composition.

[0077] In one embodiment, the at least one polycarboxylic acid is a copolymer or homopolymer of at least one of the monomers acrylic acid, methacrylic acid, 2-chloroacrylic acid, 3-chloroacrylic acid, aconitic acid, mesaconic acid, maleic acid, itaconic acid, fumaric acid, glutaconic acid, and citraconic acid.

[0078] Such a polycarboxylic acid does not include a polymerizable and ethylenically unsaturated double bond. Furthermore, such a polycarboxylic acid has a weight average molecular weight of 10000 to 130000 g/mol. If the weight average molecular weight is less than 10000 g/mol, the strength of a cured body decreases easily, and the adhesive strength to a tooth tends to decrease. If the weight average molecular weight is more than 130000 g/mol, operativity tends to decrease.

[0079] All polycarboxylic acids of component (b) being comprised in the dental RMGI composition (or in all parts of a kit, if a kit is present) are provided in an amount of 2 to 20 weight percent, preferably 2 to 12 weight percent, and more preferably 3 to 7 weight percent based on the total weight of the dental RMGI composition.

[0080] In one embodiment, the dental resin modified glass-ionomer composition further comprises [0081] (g) at least one non-reactive filler, preferably a glass flake and/or an inert silica particle.

[0082] Examples of fillers that are not ionically reactive towards acidic moieties include, but are not limited to, an inorganic salt, fluoride, glass flake, aluminosilicate glass, aluminoborosilicate glass, quartz, silica, zirconia, zirconia-silica, or a polymeric filler.

[0083] Specific examples can be selected from the group consisting of strontium fluoride, ytterbium fluoride, yttrium fluoride, barium sulfate, barium tungstate, zirconium oxide, quartz, inert silica particle, and polymeric filler. Suitable silica particle fillers include fumed silica, colloidal silica, and/or precipitated silica. Examples of silica particle fillers include Aerosil® series such as OX-50, OX-130, and OX-200 silica sold by Degussa (Ridgefield Park, N.J.), and Cab-O-Sil® MS and Cab-O-Sil® TS-530 silica sold by Cabot Corp (Tuscola, Ill.).

[0084] All non-reactive fillers of component (g) being comprised in the dental RMGI composition (or in all parts of a kit, if a kit is present) are provided in an amount of 10 to 50 weight percent, preferably 12 to 35 weight percent, and more preferably 15 to 25 weight percent based on the total weight of the dental RMGI composition.

[0085] In one embodiment, the dental resin modified glass-ionomer composition further comprises [0086] (h) at least one polymerization initiator system selected from the group consisting of a photoinitiator system, a redox initiator system, or a combination thereof.

[0087] In one embodiment, a photoinitiator is incorporated in the composition. The photoinitiator can be any compound or combination of compounds that can generate free radicals upon exposure to a light source and cause the polymerization or hardening of the composition. The light source can be any dental curing light that emits light in the visible or ultraviolet range. Examples of photoinitiators include, but are not limited to, diketone compounds; benzoin; benzoin ethers and esters; 2,2-diethoxy acetophenone; monoacylphosphine oxide; bisacylphosphine oxide; diaryliodonium salt; triaryl sulfonium salt, silyl glyoxylates; and any mixture thereof. Examples of diketone compounds include, but are not limited to, camphorquinone and 1-phenyl-1,2-propanedione.

[0088] Additionally, a co-initiator can be used together with a photoinitiator to enhance curing efficiency. Co-initiators include tertiary amine and sulfinate compounds. Exemplary co-initiators include, but are not limited to, ethyl 4-(N,N-dimethylamino) benzoate; 4-(N,N-dimethylamino) benzoic acid; 4-(N,N-dimethylamino) benzonitrile; 4-(N,N-dimethylamino) benzaldehyde; 2-(ethylhexyl)-4-(N,N-dimethylamino) benzoate; N,N-dimethylaminoethyl methacrylate; N,N-dimethylaminophenethyl alcohol; sodium benzenesulfinate; germanium hydrides (e.g. Ph.sub.3GeH); silicium hydrides, phosphines (e.g. Ph.sub.3P); and sodium toluenesulfinate.

[0089] According to one embodiment, the photoinitiator system includes a combination of camphorquinone and a tertiary amine.

[0090] All polymerization initiator systems of component (h) being comprised in the dental RMGI composition (or in all parts of a kit, if a kit is present) are provided in an amount of 0.01 to 10 weight percent, preferably 0.2 to 8 weight percent, and more preferably 0.5 to 5 weight percent based on the total weight of the dental RMGI composition.

[0091] According to another embodiment, a redox initiator system is incorporated in the dental RMGI composition. A redox initiator system usually comprises at least one reducing agent and at least one oxidizing agent. When the reducing agent and the oxidizing agent are mixed together, a redox reaction proceeds that generates free radicals and initiates the polymerization of monomers, resulting in the curing or hardening of the mixed composition.

[0092] The reducing agents include, but are not limited to, aromatic sulfinate salt; aliphatic sulfinate salt; thiourea; substituted thiourea; Fe(II) salt; Cu(I) salt; Co(II) salt; ascorbic acid; ascorbic acid derivatives and salts; barbituric acid; and barbituric acid derivatives and salts.

[0093] According to embodiments of the present invention, the reducing agent or agents may be present in an amount from 0.01 to 10 weight percent based on the total weight of the dental RMGI composition.

[0094] The oxidizing agents include, but are not limited to, a tertiary hydroperoxide compound with at least one hydroperoxide group attached to at least one tertiary carbon, such as cumene hydroperoxide; a Cu(II) salt, such as Cu(II) acetylacetonate, Cu(II) benzoylacetonate, or Cu(II) cyclohexylbutyrate; a Fe(III) salt, such as FeCl.sub.3, Fe(III) benzoyl acetonate, or Fe(III) cyclohexylbutyrate; a Co(III) salt; persulfate salt; permanganate salt; and combinations of these.

[0095] According to embodiments of the present invention, the oxidizing agent or agents may be present in an amount from 0.01 to 10 weight percent based on the total weight of the dental RMGI composition.

[0096] The photoinitiator system and the redox initiator system can be incorporated alone or in combination.

[0097] Further, the object of the present invention is also solved by a kit comprising such a dental resin modified glass-ionomer composition wherein the kit comprises at least a first part and at least a second part;

[0098] wherein the first part comprises [0099] (c) at least one compound having at least one phosphorous atom selected from the group consisting of a (meth)acrylate having at least one phosphate group, a (meth)acrylate having at least one phosphonic acid group, and an acrylic ether having at least one phosphonic acid group; and [0100] (d) at least one bisacrylamide having formula (I); [0101] and wherein the second part comprises [0102] (a) at least water; [0103] (b) at least one polycarboxylic acid; and [0104] (d) at least one bisacrylamide having formula (I).

[0105] The provision of a kit comprising such a dental resin modified glass-ionomer composition in a first and a second part maintains at the beginning a separation of various reactive components. Upon mixing of the components of the inventive dental RMGI composition, the resulting mixture is suitable for use in a variety of direct and indirect dental applications, including but not limited to fillings, orthodontic retainers, bridges, space maintainers, tooth replacement appliances, dentures, crowns, posts, jackets, inlays, onlays, facings, veneers, facets, implants, abutments, cements, bonding agents, and splints, and provide improved bonding strengths to dental substrates, such as dentin, enamel, dental alloy, zirconia, ceramic material, or porcelain, and yet maintain other desirable properties.

[0106] In a preferred embodiment thereof, the first part further comprises [0107] (f) at least one reactive filler, preferably a fluoroaluminosilicate filler; [0108] and the second part further comprises [0109] (e) at least one acrylamide having formula (II); and [0110] (f) at least one non-reactive filler, preferably a glass flake and/or an inert silica particle.

[0111] In a further preferred embodiment thereof, the first and the second part is a paste, respectively; or that the first part is a powder and the second part is a liquid.

[0112] The two pastes can be mixed in any volume ratio. In one embodiment, the two pastes are mixed in a volume ratio between about 10:1 to about 1:10. In one embodiment, the two pastes are mixed in 1:1 volume ratio.

[0113] The two parts need to be mixed just prior to application, applied to a restoration material, and hardened inside a patient's mouth by self-curing or the combination of self-curing or light-curing.

[0114] Commonly, it is done manually by a spatula or by applying a mounted static mixer as mixing tip arranged at the exit of a double cartridge, which automatically blends the two parts of the kit prior to application.

[0115] The present invention thus addresses the problem of providing an enhanced adhesive strength towards tooth structure, and a simplified application procedure.

[0116] The following non-limiting examples are provided to illustrate an embodiment of the present invention and to facilitate understanding of the invention but are not intended to limit the scope of the invention, which is defined by the claims appended hereto.

[0117] All inventive and comparative experiments have been executed by making use of dental resin modified glass-ionomer compositions wherein the first and the second part is a paste.

[0118] All values given in Tables 1, 2, 5, and 6 are given in weight percentages of the respective oxidizing paste or reducing paste. All components of the respective oxidizing paste or reducing paste together provide a total sum of 100 weight percent for each individual paste.

Preparation:

[0119] For preparation of the reducing paste. PAA was first solved in distilled water by pre-mixing in the SpeedMixer DAC 600-2 VAC-P (Hauschild & Co. KG. E-QC-1936). All other components according to the tables were directly weighed into a 50 mL plastic container per paste (PP 30. Hauschild & Co. KG). For preparation of oxidizing paste also all components according to the tables were directly weighed into a 50 mL plastic container per paste (PP 30. Hauschild & Co. KG). Solid components were put in first. liquids last; batch sizes per paste was 15-45 g. Each container was subsequently closed with a lid with a hole in it and placed in the SpeedMixer. Mixing was conducted twice at 2500 rpm for 2 min and once at 1000 rpm/100 mbar for 1 min. In between the mixing steps. Pastes were briefly stirred with a spatula. Finally. the hole in the lid was closed with a scotch tape and containers are stored at room temperature until further use.

[0120] For evaluation both pastes were manually filled into double-barrel syringes allowing a 1:1 volume ratio and placed in the SpeedMixer again. Mixing was conducted three times at 1000 rpm for 1 min to remove residual air-bubbles. Long mixing tips (MixPac) as used e.g. for RelyX Luting Plus were utilized to achieve homogenous extrusion of the luting cement.

Shear Bond Strength (SBS):

[0121] To determine the bond strength of the respective luting cement on dentin/enamel. Extracted human molars were embedded into a cylindrical form in a cold-cured matrix resin and finally wet ground to expose flat surfaces using 320 and 600 grit abrasive paper from buccal/lingual side. Stainless steel rods (2.985 mm in diameter) were sandblasted. Ultrasonically cleaned and dried. The respective cement was applied to the surface of the steel rod and placed onto dentin/enamel and allowed to self-cure at 37° C./50% R.H. for 5 minutes under 220 g load. The specimens (n=6 per group) were stored in 37° C. water for 24-hr. Shear bond strength (SBS) was obtained with a Zwick at crosshead speed of 1 mm/min.

Working Time (WT):

[0122] A bead-like body was formed which was periodically probed with a metal instrument at 23° C. The end of working time was defined by the transition point from viscous. spreadable material to elastic. gel-like one; the start of working time by the beginning of hand-mixing.

Setting Time (ST):

[0123] The setting time of each material was measured according to ISO 9917-2.

3-Point Bending:

[0124] Mechanical data of flexural strength (FS) and flexural modulus (E-Mod.) was measured in 3-point bending mode according to ISO 9917-2.

Opacity:

[0125] The opacity of each material was investigated using following procedure (n=2): Place a piece of film on one of the metal plates and place the mould upon it. Slightly overfill the mould with the respective material prepared in accordance with the manufacturer's instruction. Place a second piece of film on the material in the mould and cover this with the second metal plate. Thus displacing excess material. Clamp the mould together and transfer the assembly immediately to the oven maintained at 37±2° C. and ≥95% R.H. After 60 min. timed from the start of the mixing, remove the specimen from the mould and finish the periphery of the specimen to remove flash and irregularities. Afterwards, place the specimen in distilled water in the dark at 60° C. for 24 hours. Finally. the opacity of each specimen was measured using a Datacolor 800.

INVENTIVE EXAMPLES

[0126]

TABLE-US-00001 TABLE 1 Components of the respective first part (oxidizing paste) of the dental resin modified glass-ionomer compositions of inventive examples 1 to 5. Example Example Example Example Example Oxidizing Paste 1 2 3 4 5 BADEP 16.46 12.82 12.83 — — BAABE — — — 16.47 16.47 MDP 15.50 18.75 9.37 15.50 — PENTA — — 9.37 — — DHPOBA — — — — 15.50 FAS Filler 48.00 56.00 56.00 56.00 56.00 Strontium Fluoride 18.00 — — — — Ytterbium Floride — 10.00 10.00 10.00 10.00 Cumene 2.00 2.40 2.40 2.00 2.00 hydroperoxide 2-Methoxy-4- 0.03 0.03 0.03 0.03 0.03 methylphenol

TABLE-US-00002 TABLE 2 Components of the respective second part (reducing paste) of the dental resin modified glass-ionomer compositions of inventive examples 1 to 5. Example Example Example Example Example Reducing Paste 1 2 3 4 5 Polyacrylic acid 11.15 9.60 9.60 11.15 11.15 Distilled water 16.80 15.30 15.30 16.80 16.80 BADEP 50.59 38.80 38.80 — — BAABE — — — 50.60 50.60 HEAA — 8.25 8.25 — — Benzoylthiourea 2.00 1.00 1.00 2.00 2.00 Glass flakes — 27.00 27.00 — — Inert silica particle 19.45 — — 19.45 19.45

TABLE-US-00003 TABLE 3 Experimental data of the dental resin modified glass-ionomer compositions of inventive examples 1 to 5. Example Example Example Example Example 1 2 3 4 5 Working Time [s] 205 163 110 135 50 Setting Time [s] 150 135 105 110 70 Flexural Strength 25.0 31.7 35.4 28.6 34.5 [MPa] Flexural Modulus 1591 1897 2402 1241 1733 [MPa] Opacity [%] 35 19 19 39 42

TABLE-US-00004 TABLE 4 Experimental results of the dental resin modified glass-ionomer compositions of inventive examples 1 to 5. Example Example Example Example Example 1 2 3 4 5 SBS [MPa], 11.5 12.1 14.2 12.1 16.3 Dentin SBS [MPa], 19.2 24.2 20.2 20.0 21.8 Enamel

COMPARATIVE EXAMPLES

[0127]

TABLE-US-00005 TABLE 5 Components of the respective first part (oxidizing paste) of the dental resin modified glass-ionomer compositions of comparative examples 6 to 10. Example Example Example Example Example Oxidizing Paste 6 7 8 9 10 BADEP — — 12.82 — — BAABE — — — 16.47 — TEGDMA 16.47 16.47 — — 16.47 HEAA — — 18.75 15.50 15.50 MDP 15.50 — — — — DHPOBA — 15.50 — — — FAS Filler 56.00 56.00 56.00 56.00 56.00 Ytterbium Floride 10.00 10.00 10.00 10.00 10.00 Cumene 2.00 2.00 2.40 2.00 2.00 hydroperoxide 2-Methoxy-4- 0.03 0.03 0.03 0.03 0.03 methylphenol

TABLE-US-00006 TABLE 6 Components of the respective second part (reducing paste) of the dental resin modified glass-ionomer compositions of comparative examples 6 to 10. Example Example Example Example Example Reducing Paste 6 7 8 9 10 Polyacrylic acid 11.15 11.15 9.60 11.15 11.15 Distilled water 16.80 16.80 15.30 16.80 16.80 BADEP — — 38.85 — — BAABE — — — 50.60 — TEGDMA 50.60 50.60 — — 50.60 HEAA — — 8.25 — — Benzoylthiourea 2.00 2.00 1.00 2.00 2.00 Glass flakes — — 27.00 — — Inert silica particle 19.45 19.45 — 19.45 19.45

TABLE-US-00007 TABLE 7 Experimental data of the dental resin modified glass-ionomer compositions of comparative examples 6 to 10. Example Example Example Example Example 6 7 8 9 10 Working Time [s] 50 30 313 255 210 Setting Time [s] 60 75 125 145 130 Flexural Strength 36.2 33.1 31.4 23.4 11.5 [MPa] Flexural Modulus 1555 2101 2151 1352 679 [MPa] Opacity [%] 34 41 20 43 52

TABLE-US-00008 TABLE 8 Experimental results of the dental resin modified glass-ionomer compositions of comparative examples 6 to 10. Example Example Example Example Example 6 7 8 9 10 SBS [MPa], 6.0 2.30 0.82 0.90 0.10 Dentin SBS [MPa], 12.4 11.7 0.46 1.20 0.30 Enamel

[0128] While the principles of the invention have been explained in relation to certain particular embodiments, and are provided for purposes of illustration, it is to be understood that various modifications thereof will become apparent to those skilled in the art upon reading the specification. Therefore, it is to be understood that the invention disclosed herein is intended to cover such modifications as fall within the scope of the appended claims. The scope of the invention is limited only by the scope of the appended claims.